Register

COURSE DESCRIPTION:  

Hemostatic disorders such as thrombosis and bleeding conditions occur when normal hemostatic equilibrium is altered. In the thrombosis and hemostasis field, considerable advancements in clinical therapies have been made due to basic science and clinical research. In this educational activity, we will discuss the basics of primary and secondary hemostasis as well as identify the tests used to evaluate hemostasis. Please join us by registering to attend this course.

TARGET AUDIENCE:

Internal Medicine Physicians, Physician Assistants, Residents, Dentists, Advanced Practice Registered Nurses, Pharmacists and all other interested healthcare providers. 

LEARNING OBJECTIVES:

• Discuss the basics of primary and secondary hemostasis.
• Identify the tests used to evaluate hemostasis.
• Describe the approach to prolonged PT and aPTT.
• Explain the approach to thrombocytopenia and basics of ITP, TTP, HIT.
• Review the basics of hypercoagulability testing.
• Discuss the approach to duration of anticoagulation.
   

FACULTY AND DISCLOSURES:

Srikanth Nagalla, M.D., M.S.
Consult Attending, Hematology Service Hematology clinic attending
Hematology/Oncology
Miami Cancer Institute 
Chief of Benign Hematology Director of Hematology Edu

Srikanth Nagalla, M.D., M.S., faculty for this educational activity, has indicated that he is a consultant for Alexion and Alnylam. Dr. Nagalla has also indicated that he is a speaker for Alexion, DOVA, Sanofi, and Rigel. All of the relevant financial relationships listed for these individuals have been mitigated.

John Rubin, M.D., director for this educational event, owns stock in AstraZeneca and Bristol Myers Squibb. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.  

Kenneth Rosenthal, M.D., FACG, moderator for this educational event, indicated that he is on the Speaker’s Bureau for AbbVie, Inc. All of the relevant financial relationships listed for this individual has been mitigated. 

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
 

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855339, by the Florida Boards of Medicine, Podiatry, Dentistry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.